PMID: 9159159May 27, 1997Paper

Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid

Proceedings of the National Academy of Sciences of the United States of America
C HuangZ Dong

Abstract

Retinoic acid is one of the most promising drugs for chemotherapy and chemoprevention of cancer. Either blocking activator protein-1 (AP-1) activity or activating retinoic acid response element (RARE) have been proposed to be responsible for its antitumor activity. However, evidence for this hypothesis is lacking in vivo studies. To address this issue, we used an AP-1-luciferase transgenic mouse as a carcinogenesis model and new synthetic retinoids that are either selective inhibitors of AP-1 activation or selective activators of the RARE. The results showed that the SR11302, an AP-1 inhibition-specific retinoid, and other AP-1 inhibitors such as trans-retinoic acid and fluocinolone acetonide, markedly inhibit both 12-O-tetradecanoylphorbol-13-acetate-induced papilloma formation and AP-1 activation in 7,12-dimethyl benz(a)anthracene-initiated mouse skin (P < 0.05). In contrast, repeated applications of SR11235, a retinoid with RARE transactivating activity, but devoid of AP-1 inhibiting effect, did not cause significant inhibition of papilloma formation and AP-1 activation (P > 0.05). These results provide the first in vivo evidence that the antitumor effect of retinoids is mediated by blocking AP-1 activity, but not by activat...Continue Reading

References

Dec 18, 1992·Science·J M LehmannM Pfahl
May 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A SmithM A Friedman
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·R SchüleR M Evans
Nov 1, 1991·DNA and Cell Biology·C K GlassZ H Han
Dec 10, 1991·Biochimica Et Biophysica Acta·P Angel, M Karin
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·N YangR M Evans
Sep 20, 1990·The New England Journal of Medicine·W K HongL J Peters
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·K RyderD Nathans
Dec 17, 1987·Nature·V GiguereR M Evans
May 1, 1988·Molecular and Cellular Biology·D R Cohen, T Curran
Jan 1, 1994·Vitamins and Hormones·M PfahlM A Ortiz
Apr 1, 1994·Seminars in Cell Biology·P Chambon
Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·Z DongN H Colburn
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·C L WilsonL M Matrisian

❮ Previous
Next ❯

Citations

Nov 28, 2007·Archives of Pharmacal Research·Bum-Chun LeeJin Tae Hong
Jun 11, 2008·Applied Microbiology and Biotechnology·Nallasamy KumaresanSukumaran Umesh-Kumar
Sep 13, 2005·Phytochemistry·Masaaki NomuraKen-Ichi Miyamoto
Mar 7, 2002·Critical Reviews in Oncology/hematology·Janine G EinspahrDavid S Alberts
Sep 16, 1998·Current Opinion in Chemical Biology·M Resche-Rigon, H Gronemeyer
Sep 11, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Robert U SvenssonMichael D Henry
Mar 2, 2005·Nature Reviews. Drug Discovery·Adriana Maggi, Paolo Ciana
Oct 2, 2007·Nature Reviews. Drug Discovery·Lucia AltucciHinrich Gronemeyer
Jun 4, 2008·The Journal of Biological Chemistry·Nam Joo KangZigang Dong
Oct 7, 2010·Nutrition and Cancer·Mohammad Aminur RahmanDong M Shin
Nov 17, 1998·The Journal of Experimental Medicine·M RincónR A Flavell
Jan 15, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Margarita M IvanovaCarolyn M Klinge
Feb 1, 2011·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·David R CarrHeidi B Donnelly
Jul 31, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Lidiya S OrlichenkoVijay P Singh
Aug 19, 2010·Cancer Prevention Research·Jay W TichelaarMing You
Feb 4, 2006·American Journal of Respiratory Cell and Molecular Biology·Regina M DayYuichiro J Suzuki
May 23, 2013·Cell Communication and Signaling : CCS·Matthew P KeaseyTheo Hagg
Nov 12, 2002·Environmental Health Perspectives·Yi HuangChuanshu Huang
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·M R YoungN Colburn
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·G LiuZ Dong
Apr 7, 2004·The Journal of Cell Biology·Jingxia LiChuanshu Huang
Dec 25, 2012·The Journal of Steroid Biochemistry and Molecular Biology·Adriana Maggi, Alessandro Villa
Nov 24, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jade M FranklinGonzalo A Carrasco
Jul 27, 2010·Advanced Drug Delivery Reviews·Nathan Bushue, Yu-Jui Yvonne Wan
Dec 1, 2009·Toxicon : Official Journal of the International Society on Toxinology·Sergey FedorovValentin Stonik
Oct 27, 2009·Archives of Medical Research·Patricio GariglioJuan Vázquez
Apr 10, 2007·The International Journal of Biochemistry & Cell Biology·Alessia StellPaolo Ciana
Apr 3, 2003·Immunological Reviews·Mercedes Rincón, Gustavo Pedraza-Alva

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.